Objective To identify both responders and remitters, at the half-way point (week 7) to exposure-based CBTfor pediatric OCD. Furthermore, evaluate the stability of the improvements, by examining both week 7 and week 14 (post-treatment)response and remission. Method 269 children and adolescents, mean age 12.8, 51.3% female with a DSM-IV diagnosis of OCD were included. The NordLOTS study's design involved initial assignment of all participants to CBT. All analyses were conducted using an intent-to-treat model in which all available data were included in the analysis. Primary outcome measure was the CY-BOCS total score at weeks 7 and 14. We identified responders (CY-BOCS≤15) and remitters (CY-BOCS≤10) at the half-way point. Results At week 7, 38.3% were responders (95% CI 32.4–44.5%, n=95) with a CY-BOCS total score of 10.81, symptoms reduction of 52.1%, and 13.7% were remitters (95% CI 10.0–18.6%, n=34), with a CY-BOCS total score of 5.71, symptoms reduction of 75.2%. Discussion Response and remission after seven weeks of treatment were persistent. However, a substantial number of non-responders and non-remitters at the half-way point, experienced response and remission at post treatment. Conclusions Guidelines are needed to ensure that patients with OCD receive the therapy they need to achieve remission, while avoiding overutilization. Clinical trials registration information: This study was registered in Current Controlled Trials; Nordic Long-term Obsessive-compulsive disorder (OCD) Treatment Study (www.controlled-trials.com ISRCTN66385119).
|Fræðitímarit||Journal of Obsessive-Compulsive and Related Disorders|
|Útgáfustaða||Útgefið - 1 jan. 2017|
© 2016 The Authors